Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Agents for High-risk COVID-19
NCT04374019Phase 2Terminated
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin, camostat mesilate, artemisia annua, artesunate, hydroxychloroquine in coronavirus disease 2019 (COVID-19). Started May 2020; status: terminated.
02
Drugs
ivermectincamostat mesilateartemisia annuaartesunatehydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04374019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04374019.